KOTAI Biotechnologies
Latest round
- Series C
Last raised
- Oct 2018
Total raised
- $3.4M
Investors
- 1
About KOTAI Biotechnologies
Based in Osaka, Japan, established in 2016, KOTAI Biotechnologies provides an immunity AI platform and analyzes related data. In 2016, the company started business at Research Institute for Microbial Diseases, Osaka University. Immediately underwent fundraising in 2016 and 2017. Also underwent fundraising in 2019 and 2020. The company has received several grants and subsidies from AMED (Japan Agency for Medical Research and Development) since 2018 to the present to fund researches. Kotai Biotech finds receptor groups that only certain people have, such as patients with a specific disease or patients who are effective for a certain drug, among the vast variety of immune repertoires. This can be used to find very rare and important receptors, or to analyze thousands of people on the contrary. These analyses are only possible with our unique AI analysis. Therefore, it is very novel and unique. Kotai Biotech is researching whether the receptors and receptor groups found here can be used as new drug targets and biomarkers. Kotai Biotech is focusing on the field of cancer and autoimmune diseases. In addition, it is conducting researches in the field of infectious diseases under the grants from Japan Agency for Medical Research and Development (AMED). Kotai Biotech conducts joint research and development with pharmaceutical companies and bio-related companies.) The theme should be set for each individual company, such as search for drug discovery targets for each disease, patient stratification, and the development of diagnostic methods.) and share the intellectual property.
Who invested in KOTAI Biotechnologies
1 investor across 3 rounds
See all investors in KOTAI Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about KOTAI Biotechnologies
Who invested in KOTAI Biotechnologies?
KOTAI Biotechnologies has 1 investor on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KOTAI Biotechnologies raised?
KOTAI Biotechnologies has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did KOTAI Biotechnologies last raise money?
KOTAI Biotechnologies's most recent round on record is a Series C, in Oct 2018.
What does KOTAI Biotechnologies do?
Based in Osaka, Japan, established in 2016, KOTAI Biotechnologies provides an immunity AI platform and analyzes related data.
Where is KOTAI Biotechnologies headquartered?
KOTAI Biotechnologies is headquartered in Suita-shi, Japan.
Which VCs invest in companies like KOTAI Biotechnologies?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at KOTAI Biotechnologies's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like KOTAI Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.